Comparison of monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts.

Por Kievit, E., Pinedo, H. M., Schlüper, H. M., Haisma, H. J., Boven, E.
Publicado em 1996

Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.

Por Molthoff, C. F., Pinedo, H. M., Schlüper, H. M., Nijman, H. W., Boven, E.
Publicado em 1992

Enhanced transplantability of human ovarian cancer lines in cyclophosphamide-pretreated nude mice.

Por Nauta, M. M., Boven, E., Schlüper, H. M., Erkelens, C. A., Pinedo, H. M.
Publicado em 1986

Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity

Por van Hattum, A H, Hoogsteen, I J, Schlüper, H M M, Maliepaard, M, Scheffer, G L, Scheper, R J, Kohlhagen, G, Pommier, Y, Pinedo, H M, Boven, E
Publicado em 2002

Characterization of human soft-tissue sarcoma xenografts for use in secondary drug screening.

Por Boven, E., Pinedo, H. M., van Hattum, A. H., Scheffer, P. G., Peters, W. H., Erkelens, C. A., Schlüper, H. M., Kuiper, C. M., van Ark-Otte, J., Giaccone, G.
Publicado em 1998